ReviewCancers2025

Comparison of Standard of Care with or Without a PD-1/PD-L-1 Inhibitor for the Treatment of Multiple Myeloma: A Systematic Review and Meta-Analysis of Phase II and III Randomized Controlled Trials.

Zain Alsaddi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.